Literature DB >> 24041469

Characteristics of Nigerian women taking sulfadoxine/pyrimethamine twice during pregnancy for the prevention of malaria.

Nkechi G Onyeneho1, Bright C Orji, Joseph C Okeibunor, William R Brieger.   

Abstract

OBJECTIVE: To investigate the characteristics of women in Nigeria who are likely to take sulfadoxine/pyrimethamine (SP) as recommended for the prevention of malaria in pregnancy to reduce maternal and child mortality rates.
METHODS: A cross-sectional survey of 1380 women was conducted using a structured questionnaire. The women had given birth within 6months prior to the survey and were drawn from 6 local government areas in Nigeria.
RESULTS: Several demographic factors-older age bracket, ever attended school, currently living with a partner, ever married, and wealth-were significantly associated with compliance. Compliance was higher among respondents who had ever been married than among those who had never been married (χ(2)=6.733; P=0.006). Compliance was also higher among those in paid employment (χ(2)=17.110; P<0.001) and those in a higher wealth quintile (χ(2)=34.861; P<0.001). Knowledge of malaria, which included prevention of malaria in pregnancy through use of IPTp with 2 doses of SP, showed a positive association with compliance. Compliance with 2 doses of SP among those with good knowledge was higher (63.9%) than among those with poor knowledge (46.9%) (χ(2)=26.981; P<0.001).
CONCLUSION: The present findings could help in targeting health education programs to specific subgroups of women to increase compliance with the recommended 2 doses of SP for the prevention of malaria in pregnancy.
© 2013.

Entities:  

Keywords:  Intermittent preventive treatment; Malaria; Nigeria; Pregnancy; Sulfadoxine/pyrimethamine

Mesh:

Substances:

Year:  2013        PMID: 24041469     DOI: 10.1016/j.ijgo.2013.05.019

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  6 in total

1.  Accessibility, availability and utilisation of malaria interventions among women of reproductive age in Kilosa district in central Tanzania.

Authors:  Susan F Rumisha; Maria M Zinga; Carolyn A Fahey; Dorothy Wei; Veneranda M Bwana; Malongo R S Mlozi; Elizabeth H Shayo; Robert C Malima; Benjamin K Mayala; Grades Stanley; Tabitha Mlacha; Leonard E G Mboera
Journal:  BMC Health Serv Res       Date:  2014-10-02       Impact factor: 2.655

2.  Anaemia is typical of pregnancies: capturing community perception and management of anaemia in pregnancy in Anambra State, Nigeria.

Authors:  Nkechi G Onyeneho; Obianuju U Igweonu
Journal:  J Health Popul Nutr       Date:  2016-08-31       Impact factor: 2.000

3.  Factors associated with compliance to recommended micronutrients uptake for prevention of anemia during pregnancy in urban, peri-urban, and rural communities in Southeast Nigeria.

Authors:  Nkechi G Onyeneho; Ngozi I'Aronu; Ngozi Chukwu; Uju Patricia Agbawodikeizu; Malgorzata Chalupowski; S V Subramanian
Journal:  J Health Popul Nutr       Date:  2016-11-02       Impact factor: 2.000

4.  Coverage of intermittent preventive treatment of malaria in pregnancy in four sub-Saharan countries: findings from household surveys.

Authors:  Clara Pons-Duran; Mireia Llach; Charfudin Sacoor; Sergi Sanz; Eusebio Macete; Iwara Arikpo; Máximo Ramírez; Martin Meremikwu; Didier Mbombo Ndombe; Susana Méndez; Manu F Manun'Ebo; Ranto Ramananjato; Victor R Rabeza; Maya Tholandi; Elaine Roman; Franco Pagnoni; Raquel González; Clara Menéndez
Journal:  Int J Epidemiol       Date:  2021-05-17       Impact factor: 7.196

5.  Perception and attitudes towards preventives of malaria infection during pregnancy in Enugu State, Nigeria.

Authors:  Nkechi G Onyeneho; Ngozi Idemili-Aronu; Ijeoma Igwe; Felicia U Iremeka
Journal:  J Health Popul Nutr       Date:  2015-11-18       Impact factor: 2.000

6.  Knowledge and Utilisation of Intermittent Preventive Treatment of Malaria among Pregnant Women in Muramvya Health District, Burundi, 2018.

Authors:  Edouard Nkunzimana; Mu'awiyyah Sufiyan Babale
Journal:  East Afr Health Res J       Date:  2020-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.